{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:05:16Z","timestamp":1792886716647,"version":"4.5.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome is a new term indicating a health condition that emphasizes the interconnection of diabetes (type 2 diabetes [T2D]), insulin resistance (IR), CKD, and cardiovascular disease; the pathogenic links between these conditions seem to start with IR\/T2D. The incidence and prevalence of this condition are increasing in parallel with the contemporary Western culture consumption of ultra-processed foods. Thermic processing of food increases the formation of pro-oxidant and proinflammatory advanced glycation end products (AGEs), which are partially absorbed into the body increasing the body pool of AGEs, which eventually produces chronic tissue injury, including IR. In this article, we review the literature and present experimental and human data supporting the hypothesis that AGEs in food are major contributory factors to toxicity of ultra-processed foods. We postulate that although hyperglycemia accompanying the diabetic state increases endogenous AGE production, ingestion of these compounds in food may also initiate oxidative stress that eventually causes IR and T2D. Several small clinical trials have studied the effect of dietary AGE intake restriction over variable periods of time, and most of them have demonstrated significant reduction not only in circulating markers of AGEs but also in markers of inflammation and oxidative stress in healthy as well as in CKM subjects. An AGE-restricted diet has also been shown to improve markers of IR. Final proof of a therapeutic role for the low AGE diet will require large, prospective, and randomized clinical trials, which may be challenging to accomplish. We believe, however, that current available data make it reasonable and prudent to advise limitation of dietary AGEs in the general population as well as in CKM patients. Importantly, the simple changes in culinary techniques suggested here can markedly affect AGE content in food and be incorporated as meal patterns consistent with most currently available recommendations promoting CKM health.<\/jats:p>","DOI":"10.2215\/cjn.0000000859","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T16:00:32Z","timestamp":1754668832000},"page":"332-345","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Dietary Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic Complications"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-1134","authenticated-orcid":false,"given":"Jaime","family":"Uribarri","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[{"name":"Providence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington"},{"name":"Nephrology Division and Kidney Research Institute, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"10397","key":"B1-20260318","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet."},{"issue":"3","key":"B2-20260318","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/dc22-1024","article-title":"Combination of multiple low-risk lifestyle behaviors and incident type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies","volume":"46","author":"Khan","year":"2023","journal-title":"Diabetes Care."},{"issue":"20","key":"B3-20260318","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"21","key":"B4-20260318","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/jama.2023.22276","article-title":"Here's what to know about cardiovascular-kidney-metabolic syndrome, newly defined by the AHA","volume":"330","author":"Larkin","year":"2023","journal-title":"JAMA."},{"issue":"suppl 1","key":"B5-20260318","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ndt\/gfae212","article-title":"Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease","volume":"40","author":"Alicic","year":"2025","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B6-20260318","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","article-title":"American Association of Clinical Endocrinology Consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update","volume":"29","author":"Samson","year":"2023","journal-title":"Endocr Pract."},{"key":"B7-20260318","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejim.2025.03.017","article-title":"Ultra-processed foods and cardio-kidney-metabolic syndrome: a review of recent evidence","volume":"136","author":"Kanbay","year":"2025","journal-title":"Eur J Intern Med."},{"issue":"1","key":"B8-20260318","doi-asserted-by":"crossref","first-page":"100121","DOI":"10.1016\/j.advnut.2023.09.009","article-title":"Ultra-processed foods and human health: a systematic review and meta-analysis of prospective cohort studies","volume":"15","author":"Vitale","year":"2024","journal-title":"Adv Nutr."},{"issue":"5","key":"B9-20260318","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1017\/S1368980018003762","article-title":"Ultra-processed foods: what they are and how to identify them","volume":"22","author":"Monteiro","year":"2019","journal-title":"Public Health Nutr."},{"issue":"8","key":"B10-20260318","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/nu11081704","article-title":"The healthfulness of the US packaged food and beverage supply: a cross-sectional study","volume":"11","author":"Baldridge","year":"2019","journal-title":"Nutrients."},{"issue":"7","key":"B11-20260318","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc22-1993","article-title":"Ultra-processed food consumption and risk of type 2 diabetes: three large prospective U.S. cohort studies","volume":"46","author":"Chen","year":"2023","journal-title":"Diabetes Care."},{"issue":"5","key":"B12-20260318","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/1541-4337.12593","article-title":"Dietary advanced glycation end-products: perspectives linking food processing with health implications","volume":"19","author":"Zhang","year":"2020","journal-title":"Compr Rev Food Sci Food Saf."},{"issue":"1","key":"B13-20260318","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2019.05.008","article-title":"Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of Ad libitum food intake","volume":"30","author":"Hall","year":"2019","journal-title":"Cell Metab."},{"issue":"4","key":"B14-20260318","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3945\/an.115.008433","article-title":"Dietary advanced glycation end products and their role in health and disease","volume":"6","author":"Uribarri","year":"2015","journal-title":"Adv Nutr."},{"issue":"13","key":"B15-20260318","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/cells12131684","article-title":"Dietary advanced glycation end products: their role in the insulin resistance of aging","volume":"12","author":"Portero-Otin","year":"2023","journal-title":"Cells."},{"issue":"5","key":"B16-20260318","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/db05-0857","article-title":"Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species","volume":"55","author":"Riboulet-Chavey","year":"2006","journal-title":"Diabetes."},{"issue":"6","key":"B17-20260318","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","article-title":"N\u03b5-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance","volume":"34","author":"Gaens","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"B18-20260318","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia."},{"issue":"2","key":"B19-20260318","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S0954422420000104","article-title":"The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: a narrative review","volume":"33","author":"Garay-Sevilla","year":"2020","journal-title":"Nutr Res Rev."},{"issue":"1","key":"B20-20260318","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules."},{"issue":"6","key":"B21-20260318","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J Am Diet Assoc."},{"issue":"1","key":"B22-20260318","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41598-017-02268-0","article-title":"Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials","volume":"7","author":"Baye","year":"2017","journal-title":"Sci Rep."},{"issue":"12","key":"B23-20260318","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.3390\/nu13124398","article-title":"Exposure of caenorhabditis elegans to dietary N\u03b5-carboxymethyllysine emphasizes endocytosis as a new route for intestinal absorption of advanced glycation end products","volume":"13","author":"Dubois","year":"2021","journal-title":"Nutrients."},{"issue":"1","key":"B24-20260318","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3945\/an.116.013912","article-title":"Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases","volume":"8","author":"Gugliucci","year":"2017","journal-title":"Adv Nutr."},{"issue":"2","key":"B25-20260318","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cpt.148","article-title":"Emerging targets for therapeutic development in diabetes and its complications: the RAGE signaling pathway","volume":"98","author":"Litwinoff","year":"2015","journal-title":"Clin Pharmacol Ther."},{"issue":"5","key":"B26-20260318","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"4","key":"B27-20260318","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/biom14040412","article-title":"The RAGE axis: a relevant inflammatory hub in human diseases","volume":"14","author":"Rojas","year":"2024","journal-title":"Biomolecules."},{"issue":"11","key":"B28-20260318","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med (Berl)."},{"issue":"6","key":"B29-20260318","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.semnephrol.2009.07.013","article-title":"Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and\/or prevention of reduced renal function in elderly persons","volume":"29","author":"Vlassara","year":"2009","journal-title":"Semin Nephrol."},{"issue":"32","key":"B30-20260318","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1073\/pnas.0401588101","article-title":"Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"37","key":"B31-20260318","doi-asserted-by":"crossref","first-page":"13801","DOI":"10.1073\/pnas.0600362103","article-title":"Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor","volume":"103","author":"Cai","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"B32-20260318","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/acs.jafc.8b06748","article-title":"Metabolization of the advanced glycation end product N-\u03b5-Carboxymethyllysine (CML) by different probiotic E. coli strains","volume":"67","author":"Hellwig","year":"2019","journal-title":"J Agric Food Chem."},{"issue":"4","key":"B33-20260318","doi-asserted-by":"crossref","first-page":"G556","DOI":"10.1152\/ajpgi.00055.2006","article-title":"The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock","volume":"291","author":"Raman","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"3","key":"B34-20260318","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/ijms23031766","article-title":"The role of AGE-RAGE signalling as a modulator of gut permeability in diabetes","volume":"23","author":"Snelson","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"5","key":"B35-20260318","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B36-20260318","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/mnfr.201300847","article-title":"Maillard reaction products modulate gut microbiota composition in adolescents","volume":"58","author":"Seiquer","year":"2014","journal-title":"Mol Nutr Food Res."},{"issue":"9","key":"B37-20260318","doi-asserted-by":"crossref","first-page":"e0184789","DOI":"10.1371\/journal.pone.0184789","article-title":"Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial","volume":"12","author":"Yacoub","year":"2017","journal-title":"PLoS One."},{"issue":"48","key":"B38-20260318","doi-asserted-by":"crossref","first-page":"47376","DOI":"10.1074\/jbc.M301088200","article-title":"Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism","volume":"278","author":"Miele","year":"2003","journal-title":"J Biol Chem."},{"issue":"6","key":"B39-20260318","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/en.2008-1342","article-title":"Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis","volume":"150","author":"Zhao","year":"2009","journal-title":"Endocrinology."},{"issue":"1","key":"B40-20260318","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1038\/s41598-018-26482-6","article-title":"Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression","volume":"8","author":"Pinto-Junior","year":"2018","journal-title":"Sci Rep."},{"issue":"39","key":"B41-20260318","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1073\/pnas.1205847109","article-title":"Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1","volume":"109","author":"Cai","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"B42-20260318","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3390\/ijms24032261","article-title":"Advanced glycation end products effects on adipocyte niche stiffness and cell signaling","volume":"24","author":"Izgilov","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"2","key":"B43-20260318","doi-asserted-by":"crossref","first-page":"166029","DOI":"10.1016\/j.bbadis.2020.166029","article-title":"Molecular investigation of glycated insulin-induced insulin resistance via insulin signaling and AGE-RAGE axis","volume":"1867","author":"Walke","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"7","key":"B44-20260318","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","article-title":"Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db\/db mouse","volume":"51","author":"Hofmann","year":"2002","journal-title":"Diabetes."},{"issue":"11","key":"B45-20260318","doi-asserted-by":"crossref","first-page":"e2200046","DOI":"10.1002\/mnfr.202200046","article-title":"Dietary advanced glycation end-products affects the progression of early diabetes by intervening in carbohydrate and lipid metabolism","volume":"66","author":"Wu","year":"2022","journal-title":"Mol Nutr Food Res."},{"issue":"9","key":"B46-20260318","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3390\/nu12092497","article-title":"Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation","volume":"12","author":"Mastrocola","year":"2020","journal-title":"Nutrients."},{"issue":"8","key":"B47-20260318","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/diabetes.54.8.2314","article-title":"Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake","volume":"54","author":"Sandu","year":"2005","journal-title":"Diabetes."},{"issue":"5","key":"B48-20260318","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/dmrr.1188","article-title":"Serum advanced glycation end products (AGEs) are associated with insulin resistance","volume":"27","author":"Tan","year":"2011","journal-title":"Diabetes Metab Res Rev."},{"issue":"7","key":"B49-20260318","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc11-0091","article-title":"Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1","volume":"34","author":"Uribarri","year":"2011","journal-title":"Diabetes Care."},{"issue":"2","key":"B50-20260318","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00726-013-1542-9","article-title":"Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects","volume":"46","author":"Forbes","year":"2014","journal-title":"Amino Acids."},{"issue":"4","key":"B51-20260318","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"4","key":"B52-20260318","first-page":"1272","article-title":"Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients","volume":"27","author":"Jara","year":"2012","journal-title":"Nutr Hosp."},{"issue":"3","key":"B53-20260318","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.clnu.2017.03.019","article-title":"Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: the CODAM study","volume":"37","author":"Scheijen","year":"2018","journal-title":"Clin Nutr."},{"issue":"22","key":"B54-20260318","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/nu14224929","article-title":"Association of \u03b1-dicarbonyls and advanced glycation end products with insulin resistance in non-diabetic young subjects: a case-control study","volume":"14","author":"Csongov\u00e1","year":"2022","journal-title":"Nutrients."},{"issue":"5","key":"B55-20260318","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.diabet.2017.01.001","article-title":"Increased odds of metabolic syndrome with consumption of high dietary advanced glycation end products in adolescents","volume":"43","author":"Saha","year":"2017","journal-title":"Diabetes Metab."},{"issue":"5","key":"B56-20260318","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/ajcn.2009.28737","article-title":"A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases","volume":"91","author":"Birlouez-Aragon","year":"2010","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"B57-20260318","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2337\/dc13-0842","article-title":"Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women","volume":"37","author":"Mark","year":"2014","journal-title":"Diabetes Care."},{"issue":"6","key":"B58-20260318","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3945\/ajcn.115.125427","article-title":"Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial","volume":"103","author":"de Courten","year":"2016","journal-title":"Am J Clin Nutr."},{"issue":"10","key":"B59-20260318","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00125-016-4053-x","article-title":"Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial","volume":"59","author":"Vlassara","year":"2016","journal-title":"Diabetologia."},{"issue":"2","key":"B60-20260318","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s40200-020-00614-0","article-title":"Low advanced glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a randomized clinical trial","volume":"19","author":"Goudarzi","year":"2020","journal-title":"J Diabetes Metab Disord."},{"issue":"6","key":"B61-20260318","doi-asserted-by":"crossref","first-page":"e156950","DOI":"10.1172\/jci.insight.156950","article-title":"A 4-week high-AGE diet does not impair glucose metabolism and vascular function in obese individuals","volume":"7","author":"Linkens","year":"2022","journal-title":"JCI Insight."},{"issue":"1","key":"B62-20260318","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3164\/jcbn.12-40","article-title":"Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus","volume":"52","author":"Lu\u00e9vano-Contreras","year":"2013","journal-title":"J Clin Biochem Nutr."},{"issue":"1","key":"B63-20260318","first-page":"1","article-title":"Impact of dietary advanced glycation end-product restriction on insulin resistance and anthropometric indices in coronary artery patients treated with percutaneous coronary intervention: a randomized controlled trial","volume":"18","author":"Honarkar-Shafie","year":"2023","journal-title":"J Tehran Heart Cent."},{"issue":"8","key":"B64-20260318","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/09637486.2024.2405121","article-title":"Effect of low vs high dietary-advanced glycation end products on insulin-sensitivity and inflammatory- markers among overweight\/obese Asian-Indian adults-A randomised controlled trial","volume":"75","author":"Bai","year":"2024","journal-title":"Int J Food Sci Nutr."},{"issue":"1","key":"B65-20260318","doi-asserted-by":"crossref","first-page":"e1901290","DOI":"10.1002\/mnfr.201901290","article-title":"Reduction in circulating advanced glycation end products by mediterranean diet is associated with increased likelihood of type 2 diabetes remission in patients with coronary heart disease: from the cordioprev study","volume":"65","author":"Gutierrez-Mariscal","year":"2021","journal-title":"Mol Nutr Food Res."},{"issue":"3","key":"B66-20260318","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/osp4.646","article-title":"Dietary advanced glycation products and their associations with insulin sensitivity and body weight: a 16-week randomized clinical trial","volume":"9","author":"kahleova","year":"2022","journal-title":"Obes Sci Pract."},{"issue":"1","key":"B67-20260318","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000381315","article-title":"The low AGE diet: a neglected aspect of clinical nephrology practice?","volume":"130","author":"Uribarri","year":"2015","journal-title":"Nephron."},{"issue":"2","key":"B68-20260318","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"114","key":"B69-20260318","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ki.2009.401","article-title":"Role of oxidants\/inflammation in declining renal function in chronic kidney disease and normal aging","volume":"76","author":"Vlassara","year":"2009","journal-title":"Kidney Int."},{"issue":"24","key":"B70-20260318","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.91.24.11704","article-title":"Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats","volume":"91","author":"Vlassara","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"B71-20260318","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/dmrr.283","article-title":"Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products","volume":"18","author":"Zheng","year":"2002","journal-title":"Diabetes Metab Res Rev."},{"issue":"3","key":"B72-20260318","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10522-019-09808-3","article-title":"The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging","volume":"20","author":"Teissier","year":"2019","journal-title":"Biogerontology."},{"issue":"1","key":"B73-20260318","doi-asserted-by":"crossref","first-page":"101503","DOI":"10.1016\/j.diabet.2023.101503","article-title":"Reduction of circulating methylglyoxal levels by a mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: from the CORDIOPREV randomized controlled trial","volume":"50","author":"Gutierrez-Mariscal","year":"2024","journal-title":"Diabetes Metab."},{"issue":"11","key":"B74-20260318","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2009-0089","article-title":"Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1","volume":"94","author":"Vlassara","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"B75-20260318","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.ASN.0000051593.41395.B9","article-title":"Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients","volume":"14","author":"Uribarri","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B76-20260318","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/0003319720916301","article-title":"Advanced glycation end products and their involvement in cardiovascular disease","volume":"71","author":"Yubero-Serrano","year":"2020","journal-title":"Angiology."},{"issue":"8","key":"B77-20260318","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2217\/bmm-2020-0060","article-title":"Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis","volume":"14","author":"Pinto","year":"2020","journal-title":"Biomark Med."},{"key":"B78-20260318","doi-asserted-by":"crossref","first-page":"9570616","DOI":"10.1155\/2019\/9570616","article-title":"Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"13","key":"B79-20260318","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.3390\/ijms25137319","article-title":"Generation and accumulation of various advanced glycation end-products in cardiomyocytes may induce cardiovascular disease","volume":"25","author":"Takata","year":"2024","journal-title":"Int J Mol Sci."},{"issue":"5","key":"B80-20260318","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/ijms23052404","article-title":"Advanced glycation end products: a sweet flavor that embitters cardiovascular disease","volume":"23","author":"Pinto","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"B81-20260318","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(97)00192-5","article-title":"Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit","volume":"136","author":"Panagiotopoulos","year":"1998","journal-title":"Atherosclerosis."},{"issue":"5","key":"B82-20260318","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.15.5.571","article-title":"Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"4","key":"B83-20260318","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF03401582","article-title":"Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits","volume":"1","author":"Vlassara","year":"1995","journal-title":"Mol Med."},{"issue":"24","key":"B84-20260318","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1073\/pnas.89.24.12043","article-title":"Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications","volume":"89","author":"Vlassara","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"B85-20260318","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ajcn\/85.5.1236","article-title":"Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus","volume":"85","author":"Negrean","year":"2007","journal-title":"Am J Clin Nutr."},{"issue":"9","key":"B86-20260318","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","article-title":"Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes","volume":"29","author":"Stirban","year":"2006","journal-title":"Diabetes Care."},{"issue":"10","key":"B87-20260318","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/dc07-0320","article-title":"Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects","volume":"30","author":"Uribarri","year":"2007","journal-title":"Diabetes Care."},{"issue":"3","key":"B88-20260318","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.CIR.0000135587.92455.0D","article-title":"High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients","volume":"110","author":"Cai","year":"2004","journal-title":"Circulation."},{"issue":"3","key":"B89-20260318","first-page":"105","article-title":"Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: from the CORDIOPREV study","volume":"35","author":"Yubero-Serrano","year":"2023","journal-title":"Clin Investig Arterioscler."},{"issue":"1","key":"B90-20260318","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2014.04.013","article-title":"Advanced glycation\/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults","volume":"235","author":"Kizer","year":"2014","journal-title":"Atherosclerosis."},{"issue":"10","key":"B91-20260318","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1532-5415.2009.02438.x","article-title":"Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"57","author":"Semba","year":"2009","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"B92-20260318","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1152\/ajpcell.00350.2007","article-title":"AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation","volume":"294","author":"Cai","year":"2008","journal-title":"Am J Physiol Cell Physiol."},{"issue":"4","key":"B93-20260318","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2353\/ajpath.2009.090138","article-title":"Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia","volume":"175","author":"Torreggiani","year":"2009","journal-title":"Am J Pathol."},{"issue":"6","key":"B94-20260318","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.advnut.2023.09.005","article-title":"Perspective: a research roadmap about ultra-processed foods and human health for the United States food system: proceedings from an interdisciplinary, multi-stakeholder workshop","volume":"14","author":"O'Connor","year":"2023","journal-title":"Adv Nutr."},{"issue":"6","key":"B95-20260318","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/diabetes.52.6.1441","article-title":"Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice","volume":"52","author":"Peppa","year":"2003","journal-title":"Diabetes."},{"issue":"4","key":"B96-20260318","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1948550609359707","article-title":"Establishing causality using longitudinal hierarchical linear modeling: an illustration predicting achievement from self-control","volume":"1","author":"Duckworth","year":"2010","journal-title":"Soc Psychol Personal Sci."},{"issue":"10","key":"B98-20260318","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.3390\/nu12103143","article-title":"Long term dietary restriction of advanced glycation end-products (AGEs) in older adults with type 2 diabetes is feasible and efficacious-results from a pilot RCT","volume":"12","author":"Lotan","year":"2020","journal-title":"Nutrients."},{"issue":"8","key":"B99-20260318","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J Am Diet Assoc."},{"key":"B100-20260318","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.foodchem.2015.06.049","article-title":"Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: presentation of a dietary AGE database","volume":"190","author":"Scheijen","year":"2016","journal-title":"Food Chem."},{"issue":"11","key":"B101-20260318","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/nu16111735","article-title":"An intensive culinary intervention programme to promote healthy ageing: the SUKALMENA-InAge feasibility pilot study","volume":"16","author":"Domper","year":"2024","journal-title":"Nutrients."},{"issue":"1","key":"B102-20260318","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S0954422420000141","article-title":"Healthy eating recommendations: good for reducing dietary contribution to the body's advanced glycation\/lipoxidation end products pool?","volume":"34","author":"Del Castillo","year":"2021","journal-title":"Nutr Res Rev."},{"issue":"1","key":"B103-20260318","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/foods13010114","article-title":"Citrus peel extracts: effective inhibitors of heterocyclic amines and advanced glycation end products in grilled pork meat patties","volume":"13","author":"Xu","year":"2023","journal-title":"Foods."},{"issue":"25","key":"B104-20260318","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B105-20260318","doi-asserted-by":"crossref","first-page":"142456","DOI":"10.1016\/j.foodchem.2024.142456","article-title":"Excessive oil absorption and maillard reaction products in fried muscle foods: formation mechanisms, potential health risks and mitigation strategies","volume":"468","author":"Li","year":"2025","journal-title":"Food Chem."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:47:11Z","timestamp":1786369631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000859","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}